Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Warner Bros.Discovery, Raises Price Target to $17

Morgan Stanley Maintains Equal-Weight on Warner Bros.Discovery, Raises Price Target to $17

Morgan Stanley analyst Benjamin Swinburne maintains Warner Bros.Discovery (NASDAQ:WBD) with a Equal-Weight and raises the price target from $14 to $17.

byBenzinga Newsdesk

January 30, 2023

1 minute read

Morgan Stanley analyst Benjamin Swinburne maintains Warner Bros.Discovery (NASDAQ:WBD) with a Equal-Weight and raises the price target from $14 to $17.

Wells Fargo Maintains Overweight on Salesforce, Raises Price Target to $225

By Benzinga Newsdesk

March 2, 9:41 AM

Wells Fargo analyst Michael Turrin maintains Salesforce (NYSE:CRM) with a Overweight and raises the price target from $200 to $225.

CRM

BrainStorm Cell Therapeutics Announces Type A Meeting With FDA Granted For NurOwn; Meeting Scheduled For Jan. 11, 2023

By Bill Haddad

December 27, 7:01 AM

NEW YORK, Dec. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S.

BCLI

Maryland’s Green Rush With $55M In Weed Sales, Hemp Cultivators Sue Alaska And More Cannabis Regs

By Jelena Martinovic

November 9, 5:29 PM

Maryland's Cannabis Market Thrives With $90M In Sales In October Marylanders seem to enjoy recreational marijuana considering the latest sales data posted by the Maryland Cannabis Administration (MCA).

AAWH

Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday

By Lisa Levin

August 25, 4:25 AM

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

AKBA

Morgan Stanley Maintains Equal-Weight on Warner Bros.Discovery, Raises Price Target to $17

Related Posts

Wells Fargo Maintains Overweight on Salesforce, Raises Price Target to $225

BrainStorm Cell Therapeutics Announces Type A Meeting With FDA Granted For NurOwn; Meeting Scheduled For Jan. 11, 2023

Maryland’s Green Rush With $55M In Weed Sales, Hemp Cultivators Sue Alaska And More Cannabis Regs

Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday